NBC Securities’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76K | Hold |
1,564
| – | – | 0.01% | 1163 |
|
|
2025
Q1 | $53K | Buy |
1,564
+1,563
| +156,300% | +$53K | ﹤0.01% | 1145 |
|
|
2024
Q4 | $62 | Sell |
1
-956
| -100% | -$59.3K | 0.01% | 1006 |
|
|
2024
Q3 | $44K | Buy |
957
+119
| +14% | +$5.47K | ﹤0.01% | 1218 |
|
|
2024
Q2 | $45K | Buy |
838
+230
| +38% | +$12.4K | ﹤0.01% | 1176 |
|
|
2024
Q1 | $41K | Buy |
608
+438
| +258% | +$29.5K | ﹤0.01% | 1192 |
|
|
2023
Q4 | $10K | Sell |
170
-100
| -37% | -$5.88K | ﹤0.01% | 1693 |
|
|
2023
Q3 | $12K | Buy |
+270
| New | +$12K | ﹤0.01% | 1642 |
|